News | February 25, 2008

Masimo Plans Continuous Noninvasive Total Hemoglobin Debut

February 26, 2008 - Masimo announced it would debut its technology for noninvasive and continuous total hemoglobin (SpHb) and oxygen content (SpOC) monitoring at the World Congress of Anesthesiology (WCA) in Cape Town, South Africa, March 3, 2008.
The advent of noninvasive total hemoglobin within the Masimo Rainbow SET platform will reportedly make hemoglobin testing more convenient and broadly available to medical personnel in both the acute and outpatient settings— the measurement is said to be instantaneous and pain-free. Prior to Masimo Rainbow SET, invasive and time-consuming lab tests to determine total hemoglobin levels provided delayed and intermittent data.
Masimo expects to make SpHb and SpOC shipments to select customers for clinical use in the second half of 2008, pending regulatory clearances. There is a 510(k) pending for SpHb and SpOC in the U.S.
"From its application as a noninvasive tool for universal hemoglobin screening at routine health check-ups to the management of blood loss and blood replacement in patients experiencing acute blood loss, or those undergoing surgery— these new measurements could prove to be indispensable in a wide variety of healthcare settings," Martin Allard, M.B.Ch.B, FRC, Professor and Director of Research, Department of Anesthesiology, Loma Linda University, stated.
The Masimo Rainbow SET technology platform is designed to provide clinicians with access to real-time trending and tracking of a patient's total hemoglobin status enabling them to quickly identify conditions of anemia, or blood loss. When patients undergo blood transfusions, the company says clinicians will be able to use Masimo Rainbow SET SpHb to titrate blood and maintain hemoglobin levels within acceptable ranges. Additionally, continuous monitoring of hemoglobin levels may provide clinicians with an early warning of possible internal hemorrhaging in the emergency department, trauma and post-op settings. Because blood and hemoglobin restoration must be carefully titrated to targeted levels to avoid potentially serious morbidities, Masimo Rainbow SET SpHb provides instant feedback that the proper levels are achieved, advancing patient safety and accelerating recovery.
On July 30, 2007, The Centers for Medicare and Medicaid Services released their final National Coverage Determination (NCD) restricting coverage for the treatment of anemia, specifically Erythropoiesis Stimulating Agents (ESA) therapy, to when the hemoglobin level is less than 10g/dL. This ruling makes hemoglobin testing a prerequisite to coverage and possibly administration of ESA therapy in certain patients.
According to the company, a simple upgrade to most Masimo Radical pulse oximeters is all that will be necessary to transform an existing monitor to Masimo Rainbow SET performance - enabling integration of noninvasive total hemoglobin monitoring into any clinical setting.
For more information: www.masimo.com.

Related Content

pre-operative testing, NYU Langone, guidelines
News | June 09, 2015
Professional physician associations consider certain routine tests before elective surgery to be of low value and high...
News | March 26, 2015
March 26, 2015 — Siemens Healthcare introduced a new angiography system and new cardiac ultrasound apps at the 2015...
Nephrocheck Test System, Blood testing, contrast media

Image courtesy of Astute Medical

News | January 27, 2015
Ortho-Clinical Diagnostics Inc. announced the nationwide availability to hospitals of the Nephrocheck Test System...
blood testing, nephrocheck
News | September 30, 2014
The U.S. Food and Drug Administration has allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test...
News | June 15, 2008
June 16, 2008 - 3M Health Care said today its 3M Rapid Detection Flu A B Test demonstrated better clinical and analyt
News | March 23, 2008
March 24, 2008 – AdvanDx received Frost and Sullivan’s 2008 Technology Innovation of the Year Award in the field of r
News | March 11, 2008
March 12, 2008 - Neoteric Technology Ltd.
News | February 04, 2008
February 5, 2008 - Patients with diabetes, cardiac problems, kidney disorders or high blood pressure could benefit fr
News | January 13, 2008
January 14, 2008 – A new, hand-held creatinine monitoring system, Nova StatSensor Creatinine, was released last week
News | January 10, 2008
January 11, 2008 - Washington Hospital Center took a major step forward this week in the federally funded Project ER
Overlay Init